SMOLDERING MULTIPLE MYELOMA (SMM)
Clinical trials for SMOLDERING MULTIPLE MYELOMA (SMM) explained in plain language.
Never miss a new study
Get alerted when new SMOLDERING MULTIPLE MYELOMA (SMM) trials appear
Sign up with your email to follow new studies for SMOLDERING MULTIPLE MYELOMA (SMM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new drug head off multiple myeloma before it starts?
Disease control Recruiting nowThis study tests an investigational drug called linvoseltamab in people with two precancerous conditions—high-risk MGUS and non-high-risk smoldering multiple myeloma—that raise the risk of developing multiple myeloma. The goal is to see if the drug can eliminate abnormal plasma c…
Matched conditions: SMOLDERING MULTIPLE MYELOMA (SMM)
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 14, 2026 12:09 UTC
-
Simple blood test could catch myeloma years earlier in High-Risk groups
Diagnosis Recruiting nowThis study aims to find multiple myeloma at its earliest, precancerous stage (MGUS) in people at higher risk—Black adults and those with a family history of plasma cell disorders. By screening with a simple blood test, researchers hope to catch the disease before it causes seriou…
Matched conditions: SMOLDERING MULTIPLE MYELOMA (SMM)
Sponsor: Wake Forest University Health Sciences • Aim: Diagnosis
Last updated May 14, 2026 12:05 UTC
-
New study aims to predict who will develop multiple myeloma
Knowledge-focused Recruiting nowThis observational study is looking for biological markers that can predict if early blood disorders (MGUS or SMM) will progress to multiple myeloma, a type of blood cancer. Researchers will analyze genetics, immune cells, and mouth bacteria from 60 patients and compare them to h…
Matched conditions: SMOLDERING MULTIPLE MYELOMA (SMM)
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated May 17, 2026 03:09 UTC
-
Fiber-Rich diet may alter gut bacteria to stall a rare blood cancer
Knowledge-focused Recruiting nowThis study looks at whether eating a high-fiber, plant-based diet for 12 weeks can change the gut bacteria in people with smoldering multiple myeloma, a pre-cancer condition. Researchers will measure short-chain fatty acids in stool and track diet adherence. The goal is to see if…
Matched conditions: SMOLDERING MULTIPLE MYELOMA (SMM)
Phase: NA • Sponsor: Ciceri Fabio • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC